A mutant, noninhibitory plasminogen activator inhibitor type 1 decreases matrix accumulation in experimental glomerulonephritis

In fibrotic renal disease, elevated TGF-β and angiotensin II lead to increased plasminogen activator inhibitor type 1 (PAI-1). PAI-1 appears to reduce glomerular mesangial matrix turnover by inhibiting plasminogen activators, thereby decreasing plasmin generation and plasmin-mediated matrix degradat...

詳細記述

書誌詳細

出版年:	J Clin Invest
主要な著者:	Huang, Yufeng, Haraguchi, Masashi, Lawrence, Daniel A., Border, Wayne A., Yu, Ling, Noble, Nancy A.
フォーマット:	Artigo
言語:	Inglês
出版事項:	American Society for Clinical Investigation 2003
主題:	Article
オンライン･アクセス:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC166295/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/12897205/ https://ncbi.nlm.nih.govhttps://doi.org/10.1172/JCI18038
タグ:	タグ追加 タグなし, このレコードへの初めてのタグを付けませんか!